Celldex Therapeutics Inc (CLDX)
Stock-Based Compensation
$8.41M
Quarterly · Period ending: · USD
CLDX Stock-Based Compensation
Latest reported$8.41Mperiod ending
Latest reported$8.41Mperiod ending
CLDX Quarterly Stock-Based Comp ($0.00 → $8.41M)
Quarterly stock-based compensation
High-resolution chart · PNG
CLDX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,408,000 | |
| 8,523,000 | |
| 8,909,000 | |
| 8,801,000 | |
| 9,191,000 | |
| 9,316,000 | |
| 9,780,000 | |
| 9,620,000 | |
| 7,640,000 | |
| 7,202,000 | |
| 7,212,000 | |
| 7,121,000 | |
| 5,217,000 | |
| 4,340,000 | |
| 4,508,000 | |
| 4,496,000 | |
| 3,454,000 | |
| 3,153,000 | |
| 3,140,000 | |
| 3,029,000 | |
| 1,509,000 | |
| 1,275,000 | |
| 1,257,000 | |
| 1,250,000 | |
| 721,000 | |
| 687,000 | |
| 687,000 | |
| 707,000 | |
| 1,464,000 | |
| 1,693,000 | |
| 1,752,000 | |
| 1,793,000 | |
| 2,048,000 | |
| 2,488,000 | |
| 2,584,000 | |
| 2,739,000 | |
| 3,450,000 | |
| 3,539,000 | |
| 3,608,000 | |
| 3,796,000 | |
| 3,973,000 | |
| 3,940,000 | |
| 4,097,000 | |
| 3,869,000 | |
| 2,527,000 | |
| 2,281,000 | |
| 2,133,000 | |
| 1,958,000 | |
| 1,511,000 | |
| 1,250,000 | |
| 1,148,000 | |
| 2,016,000 | |
| 676,000 | |
| 708,000 | |
| 684,000 | |
| 526,000 | |
| 447,000 | |
| 641,000 | |
| 639,000 | |
| 570,000 | |
| 553,000 | |
| 580,000 | |
| 605,000 | |
| 583,000 | |
| 644,000 | |
| 970,000 | |
| 576,000 | |
| 618,000 | |
| 751,530 | |
| 1,112,470 | |
| 0 | |
| 0 | |
| 0 | |
| 1,622,380 | |
| 359,543,000 | |
| 0 | |
| 0 | |
| 98,897 | |
| 1,626,756,000 | |
| 0 | |
| 0 | |
| 264,255 | |
| 538,000,000 | |
| 0 | |
| 0 | |
| 121,000 | |
| 328,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 115,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |